We provide you with 20 years of free, institutional-grade data for SNDX stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of SNDX. Explore the full financial landscape of SNDX stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$3,481,570
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| Metzger Michael A | Sale | -157,307 | $16.41 | $2,582,021 | 2025-09-08 |
| Metzger Michael A | Derivatives Exercise | 157,307 | 2025-09-08 | ||
| Podlesak Dennis | Sale | -57,600 | $14.19 | $817,563 | 2025-08-18 |
| Podlesak Dennis | Derivatives Exercise | 57,600 | 2025-08-18 | ||
| Goldan Keith A. | Sale | -1,296 | $9.29 | $12,033 | 2025-07-18 |
| Metzger Michael A | Sale | -7,534 | $9.29 | $69,953 | 2025-07-18 |
| Katkin Keith | Open Market Purchase | 10,000 | $9.11 | 2025-05-19 | |
| Huber Martin H. Jr. | Open Market Purchase | 5,000 | $8.99 | 2025-05-19 | |
| Goldan Keith A. | Open Market Purchase | 3,000 | 2025-05-19 | ||
| Botwood Nicholas A.J. | Open Market Purchase | 11,765 | $8.99 | 2025-05-19 | |
| Botwood Nicholas A.J. | Initial | 2025-05-16 | |||
| Metzger Michael A | Derivatives Exercise | 6,074 | 2025-03-17 | ||
| Metzger Michael A | Sale | -7,814 | $15.05 | $117,564 | 2025-03-06 |
| Metzger Michael A | Derivatives Exercise | 7,814 | 2025-03-06 | ||
| Metzger Michael A | Sale | -13,288 | $15.5 | $206,017 | 2025-02-12 |
| Gallagher Neil | Sale | -4,618 | $15.5 | $71,597 | 2025-02-12 |
| Goldan Keith A. | Sale | -3,777 | $15.5 | $58,559 | 2025-02-12 |
| Rizo Aleksandra | Grant, award...etc | 25,000 | 2025-02-07 | ||
| Meury William | Grant, award...etc | 25,000 | 2025-02-07 | ||
| Katkin Keith | Grant, award...etc | 25,000 | 2025-02-07 | ||
| Huber Martin H. Jr. | Grant, award...etc | 25,000 | 2025-02-07 | ||
| Jarrett Jennifer | Grant, award...etc | 25,000 | 2025-02-07 | ||
| Legault Pierre | Grant, award...etc | 25,000 | 2025-02-07 | ||
| Gallagher Neil | Grant, award...etc | 41,900 | 2025-02-07 | ||
| Goldan Keith A. | Grant, award...etc | 41,900 | 2025-02-07 | ||
| Podlesak Dennis | Grant, award...etc | 50,000 | 2025-02-07 | ||
| Metzger Michael A | Grant, award...etc | 149,500 | 2025-02-07 | ||
| Goldan Keith A. | Open Market Purchase | 1,250 | $20.03 | 2024-06-17 | |
| Metzger Michael A | Grant, award...etc | 146,250 | 2024-02-09 | ||
| Goldan Keith A. | Grant, award...etc | 46,700 | 2024-02-09 | ||
| Gallagher Neil | Grant, award...etc | 47,813 | 2024-02-09 | ||
| Huber Martin H. Jr. | Grant, award...etc | 17,000 | 2024-02-09 | ||
| Jarrett Jennifer | Grant, award...etc | 17,000 | 2024-02-09 | ||
| Katkin Keith | Grant, award...etc | 17,000 | 2024-02-09 | ||
| Meury William | Grant, award...etc | 17,000 | 2024-02-09 | ||
| Morrison Briggs | Grant, award...etc | 17,000 | 2024-02-09 | ||
| Podlesak Dennis | Grant, award...etc | 34,000 | 2024-02-09 | ||
| Legault Pierre | Grant, award...etc | 17,000 | 2024-02-09 | ||
| Morrison Briggs | Sale | -52,855 | $18.27 | $965,402 | 2023-08-10 |
| Morrison Briggs | Derivatives Exercise | 52,855 | 2023-08-10 | ||
| Meury William | Sale | -83,000 | $20.46 | $1,697,815 | 2023-08-03 |
| Meury William | Derivatives Exercise | 83,000 | 2023-08-03 | ||
| Morrison Briggs | Sale | -52,855 | $20.4 | $1,078,068 | 2023-07-11 |
| Morrison Briggs | Derivatives Exercise | 52,855 | 2023-07-11 | ||
| Goldan Keith A. | Sale | -577 | $22.31 | $12,873 | 2023-06-14 |
| Morrison Briggs | Sale | -52,855 | $21.18 | $1,119,421 | 2023-06-09 |
| Morrison Briggs | Derivatives Exercise | 52,855 | 2023-06-09 | ||
| Morrison Briggs | Sale | -52,855 | $21.41 | $1,131,478 | 2023-05-10 |
| Morrison Briggs | Derivatives Exercise | 52,855 | 2023-05-10 | ||
| Morrison Briggs | Sale | -52,855 | $19.53 | $1,032,237 | 2023-04-12 |
| Morrison Briggs | Derivatives Exercise | 52,855 | 2023-04-12 | ||
| Morrison Briggs | Sale | -52,854 | $22.53 | $1,190,674 | 2023-03-14 |
| Morrison Briggs | Derivatives Exercise | 52,854 | 2023-03-14 | ||
| Ordentlich Peter | Sale | -25,000 | $25.84 | $646,093 | 2023-02-17 |
| Ordentlich Peter | Derivatives Exercise | 25,000 | 2023-02-17 | ||
| Metzger Michael A | Sale | -5,959 | $27.64 | $164,697 | 2023-02-08 |
| Metzger Michael A | Derivatives Exercise | 5,959 | 2023-02-08 | ||
| Morrison Briggs | Sale | -52,854 | $26.83 | $1,417,909 | 2023-02-08 |
| Morrison Briggs | Derivatives Exercise | 52,854 | 2023-02-08 | ||
| Katkin Keith | Grant, award...etc | 16,000 | 2023-02-03 | ||
| Legault Pierre | Grant, award...etc | 16,000 | 2023-02-03 | ||
| Jarrett Jennifer | Grant, award...etc | 16,000 | 2023-02-03 | ||
| Ordentlich Peter | Sale | -69 | $28.43 | $1,962 | 2023-02-03 |
| Podlesak Dennis | Grant, award...etc | 32,000 | 2023-02-03 | ||
| Huber Martin H. Jr. | Grant, award...etc | 16,000 | 2023-02-03 | ||
| Meury William | Grant, award...etc | 16,000 | 2023-02-03 | ||
| Legault Pierre | Sale | -39,000 | $26.74 | $1,042,895 | 2023-01-13 |
| Legault Pierre | Derivatives Exercise | 39,000 | 2023-01-13 | ||
| Ordentlich Peter | Sale | -25,000 | $25.01 | $625,285 | 2022-12-02 |
| Ordentlich Peter | Derivatives Exercise | 25,000 | 2022-12-02 | ||
| Metzger Michael A | Sale | -16,231 | $25.29 | $410,508 | 2022-10-07 |
| Metzger Michael A | Derivatives Exercise | 16,231 | 2022-10-07 | ||
| Katkin Keith | Sale | -29,899 | $25.9 | $774,411 | 2022-10-07 |
| Katkin Keith | Derivatives Exercise | 29,899 | 2022-10-07 | ||
| Metzger Michael A | Sale | -33,769 | $25.02 | $844,917 | 2022-10-04 |
| Metzger Michael A | Derivatives Exercise | 33,769 | 2022-10-04 | ||
| Katkin Keith | Sale | -4,101 | $25.07 | $102,815 | 2022-10-04 |
| Katkin Keith | Derivatives Exercise | 4,101 | 2022-10-04 | ||
| Morrison Briggs | Sale | -173,988 | $23.03 | $4,006,665 | 2022-09-21 |
| Morrison Briggs | Derivatives Exercise | 173,988 | 2022-09-21 | ||
| Morrison Briggs | Sale | -279,420 | $23.8 | $6,649,889 | 2022-09-16 |
| Morrison Briggs | Derivatives Exercise | 279,420 | 2022-09-16 | ||
| Podlesak Dennis | Sale | -78,815 | $24.2 | $1,907,150 | 2022-09-16 |
| Podlesak Dennis | Derivatives Exercise | 78,815 | 2022-09-16 | ||
| Ordentlich Peter | Sale | -25,000 | $25.04 | $625,893 | 2022-08-26 |
| Ordentlich Peter | Derivatives Exercise | 25,000 | 2022-08-26 | ||
| Legault Pierre | Sale | -24,000 | $23.02 | $552,382 | 2022-08-09 |
| Legault Pierre | Derivatives Exercise | 24,000 | 2022-08-09 | ||
| Metzger Michael A | Sale | -31,602 | $21.06 | $665,393 | 2022-07-27 |
| Metzger Michael A | Derivatives Exercise | 31,602 | 2022-07-27 | ||
| Metzger Michael A | Sale | -15,109 | $21.07 | $318,415 | 2022-07-08 |
| Metzger Michael A | Derivatives Exercise | 15,109 | 2022-07-08 | ||
| Morrison Briggs | Sale | -62,292 | $19 | $1,183,430 | 2022-07-05 |
| Morrison Briggs | Derivatives Exercise | 62,292 | 2022-07-05 | ||
| Goldan Keith A. | Grant, award...etc | 3,205 | 2022-06-15 |
The information provided in this report about SNDX stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Syndax Pharmaceuticals, Inc(NASDAQ:SNDX) 
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treat...
Website: http://www.syndax.com
Founded: 2005
Full Time Employees: 35
Sector: Healthcare
Industry: Biotechnology